Design of small-sized libraries by combinatorial assembly of linkers and functional groups to a given scaffold: application to the structure-based optimization of a phosphodiesterase 4 inhibitor.

Combinatorial chemistry and library design have been reconciled by applying simple medicinal chemistry concepts to virtual library design. The herein reported "Scaffold-Linker-Functional Group" (SLF) approach has the aim to maximize diversity while minimizing the size of a scaffold-focused library with the aid of simple molecular variations in order to identify critical pharmacophoric elements. Straightforward rules define the way of assembling three building blocks: a conserved scaffold, a variable linker, and a variable functional group. By carefully selecting a limited number of functional groups not overlapping in pharmacophoric space, the size of the library is kept to a few hundred. As an application of the SLF approach, a small-sized combinatorial library (320 compounds) was derived from the scaffold of the known phosphodiesterase 4 inhibitor zardaverine. The most interesting analogues were further prioritized for synthesis and enzyme inhibition by FlexX docking to the X-ray structure of the enzyme, leading to a 900-fold increased affinity within nine synthesized compounds and a single screening round.

[1]  Gavin Harper,et al.  Drug rings database with web interface. A tool for identifying alternative chemical rings in lead discovery programs. , 2003, Journal of medicinal chemistry.

[2]  Y. Zhao,et al.  Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity. , 2000, Science.

[3]  J. N. Wells,et al.  Cyclic nucleotide phosphodiesterase activities of pig coronary arteries. , 1975, Biochimica et biophysica acta.

[4]  R. García-Domenech,et al.  Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds. , 1999, Journal of medicinal chemistry.

[5]  D. Rognan,et al.  Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. , 2000, Journal of medicinal chemistry.

[6]  G. Hindricks,et al.  Polycystic disease of the kidneys complicating the diagnosis of myocardial echinococcosis. , 1993, European heart journal.

[7]  M. Lambert,et al.  Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram. , 2004, Journal of molecular biology.

[8]  Ramaswamy Nilakantan,et al.  A fresh look at pharmaceutical screening library design. , 2003, Drug discovery today.

[9]  E. Bradley,et al.  Informative library design as an efficient strategy to identify and optimize leads: application to cyclin-dependent kinase 2 antagonists. , 2003, Journal of medicinal chemistry.

[10]  David Weininger,et al.  SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..

[11]  Hwa-Young Kim,et al.  Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity. , 2003, Structure.

[12]  J. Hardman,et al.  Cyclic nucleotide phosphodiesterase activities from pig coronary arteries. Lack of interconvertibility of major forms. , 1980, Biochimica et biophysica acta.

[13]  Thierry Langer,et al.  Virtual combinatorial chemistry and in silico screening: Efficient tools for lead structure discovery? , 2004 .

[14]  Ajay N. Jain Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. , 2003, Journal of medicinal chemistry.

[15]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[16]  Mary Pat Beavers,et al.  Structure-based combinatorial library design: methodologies and applications. , 2002, Journal of molecular graphics & modelling.

[17]  Andy de Laet,et al.  Finding drug candidates in virtual and lost/emerging chemistry , 2000 .

[18]  G. Bemis,et al.  A minimalist approach to fragment‐based ligand design using common rings and linkers: Application to kinase inhibitors , 2004, Proteins.

[19]  H. Ke,et al.  The crystal structure of AMP-bound PDE4 suggests a mechanism for phosphodiesterase catalysis. , 2003, Biochemistry.

[20]  J Alper,et al.  Drug discovery on the assembly line. , 1994, Science.

[21]  C. Lugnier,et al.  Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation. , 1993, European heart journal.

[22]  Markus van Almsick,et al.  Efficient Algorithms To Enumerate Isomers and Diamutamers with More Than One Type of Substituent , 2000, J. Chem. Inf. Comput. Sci..

[23]  N. Baurin Drug-Like Annotation and Duplicate Analysis of a 23-Supplier Chemical Database Totalling 2.7 Million Compounds. , 2004 .

[24]  G. Byk,et al.  Approaches for introducing high molecular diversity in scaffolds: Fast parallel synthesis of highly substituted 1H-quinolin-4-one libraries , 2004, Molecular Diversity.

[25]  Cathy H. Wu,et al.  UniProt: the Universal Protein knowledgebase , 2004, Nucleic Acids Res..

[26]  J. V. Julián-Ortiz,et al.  Virtual darwinian drug design: QSAR inverse problem, virtual combinatorial chemistry, and computational screening. , 2001 .

[27]  Gisbert Schneider,et al.  SMILIB: Rapid Assembly of Combinatorial Libraries in SMILES Notation , 2003 .

[28]  Trudi Wright,et al.  Optimizing the Size and Configuration of Combinatorial Libraries , 2003, J. Chem. Inf. Comput. Sci..

[29]  C. Lugnier,et al.  Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. , 1986, Biochemical pharmacology.

[30]  Joseph Markowitz,et al.  Crystal structure of phosphodiesterase 4D and inhibitor complex1 , 2002, FEBS letters.

[31]  J. S. Dixon,et al.  Evaluation of the CASP2 docking section , 1997, Proteins.

[32]  Richard D. Taylor,et al.  Improved protein–ligand docking using GOLD , 2003, Proteins.

[33]  Jieping Zhu,et al.  Ammonium chloride-promoted four-component synthesis of pyrrolo[3,4-b]pyridin-5-one. , 2002, Journal of the American Chemical Society.

[34]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[35]  B. Lipworth Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease , 2005, The Lancet.

[36]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[37]  Daniel C. Weaver Applying data mining techniques to library design, lead generation and lead optimization. , 2004, Current opinion in chemical biology.

[38]  Matthias C. Lu The Practice of Medicinal Chemistry, 2nd Ed Edited by C. G. Wermuth (University of Louis Pasteur). Academic Press, San Diego, CA. 2003. xv + 768 pp. 22 × 28.5 cm. $174.95. ISBN 0-12-744481-5. , 2004 .

[39]  Didier Rognan,et al.  Comparative evaluation of eight docking tools for docking and virtual screening accuracy , 2004, Proteins.

[40]  Alan H. Lipkus,et al.  Exploring Chemical Rings in a Simple Topological-Descriptor Space , 2001, J. Chem. Inf. Comput. Sci..

[41]  E. Bischoff Potency, selectivity, and consequences of nonselectivity of PDE inhibition , 2004, International Journal of Impotence Research.